Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
2023 Q3 highlights: Revenue of $16.3 million , an increase of 16% compared to the corresponding period of 2022 Net income of $5.5 million , an increase of 50% compared to the corresponding period of 2022 Quarter-ending cash, cash equivalents and short-term investments of $56.0 million SANTA CLARA,
View HTML
Toggle Summary Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
SANTA CLARA, Calif. , Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for
View HTML
Toggle Summary Semler Scientific to Present at Upcoming Investor Conference
SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced Renae Cormier , CFO, will participate in
View HTML
Toggle Summary Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
2023 Q2 highlights: Revenue was $18.6 million , an increase of 25% compared to the corresponding period of 2022 Net income was $5.9 million , an increase of 44% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $51.8 million SANTA CLARA, Calif. , Aug.
View HTML
Toggle Summary Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for
View HTML
Toggle Summary Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
SANTA CLARA, Calif. , July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial
View HTML
Toggle Summary Semler Scientific to Join the Russell 2000® and 3000® Indexes
SANTA CLARA, Calif. , June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it is set to join the Russell 2000 ®
View HTML
Toggle Summary Semler Scientific Reports First Quarter 2023 Financial Results
2023 Q1 highlights: Revenue was $18.2 million , an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million , an increase of 48% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $43.0 million SANTA CLARA, Calif.
View HTML
Toggle Summary Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended
View HTML
Toggle Summary Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian , M.D., former CEO and a current member of the board of directors as chief executive officer (CEO) on an interim
View HTML

Semler Scientific

Contact us
Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051

Call us toll-free at
877-774-4211